Tamar Thompson
Director/Board Member at AVIDITY BIOSCIENCES, INC.
Net worth: - $ as of 2024-03-30
Profile
Tamar Thompson is currently serving as the Chairman of the Alexion Charitable Foundation.
Additionally, Ms. Thompson holds the position of Independent Director at Catalyst Pharmaceuticals, Inc. since 2023, Independent Director at Avidity Biosciences, Inc. since 2021, and Vice President of US Government Affairs & Policy at Alexion Pharmaceuticals, Inc. since 2019.
Ms. Thompson previously worked at Bristol Myers Squibb Co. as the Head of Federal Executive Branch Strategy from 2015 to 2019.
Ms. Thompson obtained a graduate degree from Trident University International.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AVIDITY BIOSCIENCES INC
-.--% | 2023-06-14 | 0 ( -.--% ) | - $ | 2024-03-30 |
Tamar Thompson active positions
| Companies | Position | Start |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 2021-01-10 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2019-10-31 |
| CATALYST PHARMACEUTICALS, INC. | Director/Board Member | 2023-05-24 |
| Alexion Charitable Foundation | Chairman | - |
Former positions of Tamar Thompson
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2019-10-31 |
Training of Tamar Thompson
| Trident University International | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Alexion Charitable Foundation |
- Stock Market
- Insiders
- Tamar Thompson
